Pharmaceutical Benefits Scheme post-market review of Pulmonary Arterial Hypertension medicines
Liufu, Z, Morona, J, Wyndham, A, Merlin, T
Record ID 32018000651
English
Authors' objectives:
The purpose of the Post-Market Review (PMR) of pulmonary arterial hypertension (PAH) Medicines was to review the efficacy and cost-effectiveness of PAH medicines, including the existing listing for class III patients (those with pulmonary hypertension resulting in marked limitation of physical activity) and class IV patients (those with pulmonary hypertension with inability to carry out any physical activity without symptoms) and the additional clinical place of these therapies as recommended in international guidelines.
Details
Project Status:
Completed
Year Published:
2018
URL for published report:
https://www.pbs.gov.au/info/reviews/post-market-review-pah
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
Australia
MeSH Terms
- Hypertension, Pulmonary
- Pulmonary Medicine
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.